4.4 C
New York
Thursday, February 25, 2021

Rocket Pharmaceuticals Stock

- Advertisement -

Rocket Pharmaceuticals (RCKT) Touches 5-Year High on Positive Gene Expression; Also, Prices Upsized Common Stock Offering

Rocket Pharmaceuticals reports promising Phase 1 data from its gene therapy in heart disease.RCKT shares skyrocketed, reaching a five-year high of $63.94.The pharmaceutical firm...
- Advertisement -

Must Read

- Advertisement -